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Abstract  
Background: Colorectal cancer (CRC) is the third and a second common cancer in men and women 
respectively in the world and about 1.4 million new cases diagnosed in 2012. The normal gut microflora 
consists of bacterial species. One group of them is probiotics, which confer a health benefit to the host. 
Lactobacillus reuteri (L.reuteri) is known as a probiotic, which lead to the prevention of colorectal cancer. The 
aim of this study was to assess the inhibitory effects of Lactobacillus reuteri’s cell wall on cell proliferation in 
the colorectal cancer HCT-116 cell line. 
Materials and Methods: The cells of HCT-116 cell line were grown at 37°C, 5% CO2. L.reuteri was obtained 
from the Iranian Biological Resource Center and cultured in the MRS Broth at 37°C for 48h anaerobically. The 
cell wall was prepared by the freezing-thawing procedure. So the inhibitory effect of L.reuteri on the growth 
and proliferation of HCT-116 cells was assessed by MTT assay. 
Results: The cell wall from L.reuteri inhibited cell proliferation on colorectal cancer HCT-116 cell line. It 
showed dose- and –time dependent inhibition.  
Conclusion: These results demonstrated that cell wall of L.reuteri inhibits cell proliferation of HCT-116 cell 
line. 
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Introduction 
Colorectal cancer (CRC) is the third and a second 
common cancer in men and women respectively in 
the world and about 1.4 million new cases diagnosed 
in 20121-4. In the United States in 2017, it is 
anticipated to be 135,430 individuals newly 
diagnosed with CRC and 50,260 deaths from the 
disease5. CRC is the third and fourth common cancer 
in men and women respectively in the Iran6. 
The risk factors of this disease are varied. Based on 
epidemiological studies, the consumption of red meat 
and animal fat is associated with an increased risk for 
CRC development, whereas a diet rich in fruits and 
vegetables appears to be protective against this 
illness7,8. Some studies support that the large and 
complex bacterial population hosted by the large 
intestine and known as “gut microbiota” plays a 
critical role in the CRC8,9.  
The normal gut microflora consists of bacterial species 
with morphological, physiological and genetic features 
that coexist with other colonizing microorganisms and 
competitively inhibit the growth of pathogenic 
bacteria. Nevertheless, some environmental factors 
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such as diet and drugs can alter the composition of 
the resident microbiota, with consequences for the 
health of the host10. One group of them is probiotics, 
which confer a health benefit to the host when 
administered in adequate amounts8. Probiotics seem 
to be one of the most interesting candidates for the 
treatment of colorectal cancer11. In vitro and in vivo 
studies as well as epidemiological studies have 
shown the positive role of probiotics against 
cancer12,13.  
Some Lactic acid bacteria (LAB) strains like 
Lactobacillus reuteri (L.reuteri) is known as 
probiotics, stimulate the immune system, leading to 
the prevention of colorectal cancer14. LAB are Gram-
positive, non-sporulating, nonmotile, heterotrophic 
anaerobic or facultative aerobic cocci or rods, which 
produce lactic acid as one of the main fermentation 
products of the metabolism of carbohydrates15. In 
this present study, we aimed to evaluate the effects of 
L.reuteri’s cell wall to inhibit the proliferation and 
growth of colorectal cancer HCT-116 cell line. 
Methods 
Cell culture: Colorectal cancer cell line (HCT-116) 
was purchased from the Pasteur Institute of Iran 
(National Cell Bank department), cultured in 
RPMI1640 medium containing 100 g/ml 
Streptomycin and 100 units/ml Penicillin with 10% 
fetal bovine serum (FBS) and cells were grown at 
37°C, with 5% CO2. 
Bacterial culture and preparation of cell wall: 
L.reuteri was obtained from the Iranian Biological 
Research Center (IBRC-M10755) and cultured in the 
de Man, Rogosa and Sharp medium (MRS Broth- 
Conda S.A. Spanish) at 37°C for 48h anaerobically 
by Whitley Jar Gassing System (Don whitely 
scientific- Britain). For the in vitro preparation of the 
bacterial cell wall, cultured cells was centrifuged at 
3500 rpm for 15 minutes at 4°C. Sediments were 
treated with 1ml PBS and centrifuged at 3500 rpm 
for 15 minutes at 4ᵒC for two times then stored at -
70ᵒC overnight. 1ml lysis buffer (Glycerin 10%, 
Triton X-100 1%, Lysozyme 0.2mmol and PBS), 
were added to the sediments, in some cases freez-
thaw was done, then sonicated (dr.hielscher, 
Germany) at 60% amplitude for 1 min afterward 
centrifuged 13500 rpm for 30 min at 4°C. The 
cytoplasmic (supernatant) and cell wall (sediment) 
were prepared and stored at -70°C overnight, then 
samples were dried (Freeze dryer, Christ, Germany) at 
-59°C for 5h. So various concentrations of cell wall 
(125, 250, 500, 1000, 2000 and 4000 g/ml) was 
prepared16. 
Microculture Tetrazolium Test (MTT assay): The 
inhibitory effect of L.reuteri on the growth and 
proliferation HCT-116 cells was assessed by MTT 
assay. Briefly, 25000 cells were plated in 96-well 
plates until they reached 80% confluence. After 24, 48 
and 72 h incubation, cells were treated with different 
concentrations of the cell wall. Then MTT solution 
was added to each well and the plates were incubated 
for four hours at 37°C. After solubilization of 
precipitated formazan by adding 200l DMSO and 
incubating at 37°C for 15 minutes. The optical density 
was measured at 570 nm. The inhibition rate (IR) of 
L.reuteri was evaluated using the following 
equation17: 
ODexp / average ODcon × 100. 
Results 
L.reuteri’s cell wall treatment of cells leaded to inhibit 
cell proliferation. Our study showed that the inhibitory 
effect of L.reuteri's cell wall on HCT-116 cell line. It 
was detected by MTT assay for 24, 48 and 72 hours. 
Death rate of cells was assessed as relative to 
untreated control cells. Death of cells increased with 
high dose and time. The cell wall dose of 500 g/ml 
survived cells in 24 hours (IC50 = 51.15%) and in this 
dose of cell wall the cell viability percentages were 
37.2625% and 31.1525% in 48 and 72 hours, 
respectively. While the cell viability percentages with 
cell wall dose in  250 g/ml were 69.8325% and 
54.65% in 24 and 48 hours, respectively, and in this 
dose of cell wall survived cells in 72 hours (IC50 
=50.14%), Figure 1 (A, B, C and D). 
Discussion 
Our study showed that L. reuteri's cell wall prevented 
cell proliferation on HCT-116 cell line. Inhibitory 
effects of the bacterial cell wall were increased by 
expanding in dose and time.  
A number of studies indicated that inhibitory effects of 
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LAB were vary in different cell lines with different 
supernatant doses. Yuna et al, showed that B. 
adolescentis SPM0212 cell-free supernatant inhibited 
the growth of SW480, HT-29, and Caco-2 cells. The 
cell viability percentages with different doses of 
supernatant in 25, 50, 100 and 200 g/ml were less 
than 50% in 72 hours18. While our study showed that 
the cell viability percentages with the cell wall doses 
in 250 g/ml was more than 50% and in 500, 1000 
and 2000 g/ml were less than 50% in 72 hours on 
HCT-116 cell line. Yuna concluded that B. 
adolescentis SPM0212 inhibited TNF- production, 
changes in cellular morphology and harmful fecal 
enzymes18. In addition, Angeliki Tiptiri-Kourpeti 
showed that anti-proliferation effects of increasing 
concentrations of L. casei cell-free-supernatant (CFS) 
at different time points on murine CT26 and human 
HT-29 colon cancer cells was vary. The cell viability 
percentages with CFS doses in 400 and 800 µg/ml 
were less than 50% in CT26 and of 100, 200, 400 and 
800 µg/ml were more than 50% in HT-29 cells at 72 
hours 19. While our study showed that the cell viability 
percentages with L. reuteri's cell wall doses in 250 
g/ml was more than 50% and in 500, 1000 and 2000 
g/ml were less than 50% in 72 hours on HCT-116 
cell line. These findings provide evidence for 
beneficial tumor-inhibitory, anti-proliferation and 
proapoptotic effects driven by this probiotic LAB 
strain19. A study have also indicated that the 
administration of other lactobacillus strains such as, 
the supernatants of lactobacillus acidophilus and 
lactobacillus casei reduced cell proliferation and 
increased cell apoptosis on CaCo220.  
As well, Lactobacillus delbrueckii fermentation (LBF) 
solution inhibited the growth of colorectal cancer 
SW620 cells. This study concluded that the LBF 
 
 
Figure 1. The inhibitory effect of L.reuteri's cell wall on cell proliferation in the HCT-116 colorectal cancer cell line. 
 A) Cell viability percentages treated with different doses of cell wall on cell proliferation in 24 hours, 250 g/ml (69.8325%), 500 g/ml 
(51.15%), 1000 g/ml (39.245%) and 2000 g/ml (10.93%). 
 B) Cell viability percentages treated with different doses of cell wall on cell proliferation in 48 hours, 250 g/ml (54.65%), 500 g/ml 
(37.2625%), 1000 g/ml (26.4325) and 2000 g/ml (7.325%).  
C) Cell viability percentages treated with different doses of cell wall on cell proliferation in 72 hours, 250 g/ml (50.14%), 500 g/ml 
(31.1525%), 1000 g/ml (21.9725%) and 2000 g/ml (5.36%). 
D) Cell viability percentages treated with different doses of cell wall on cell proliferation in 24, 48 and 72 hours. 
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solution induced apoptosis through the intrinsic 
caspase 3-depedent pathway, with a corresponding 
decreased expression of Bcl-2. The activity of matrix 
metalloproteinase 9, which is associated with the 
invasion of colorectal cancer cells is decreased in the 
LBF-treated cells21.  
Other studies have showed that Bifidobacterium 
bifidum supernatant inhibited the proliferation of 
Caco2 cells 20, 22. In this study the cell viability 
percentages with Bifidobacterium bifidum 
supernatant doses in 100, 200 and 300 µl/ml were 
less than 50% in 24, 48 and 72 hours, while our study 
showed cytoplasmic extraction doses of 250 and 500 
µg/ml survived cells less than 50% in 24, 48 and 72 
hours. A similar study reported anti-proliferation 
effects of L. rhamnosus GG (L. GG) on gastric and 
colorectal cancer cells. This study showed that 
increasing concentrations of L. GG homogenate and 
cytoplasmic extraction reduced the percentages of 
cell viability to nearly 55% and 65% in DLD-1 
(colon) and HGC-27 (gastric) cancer cell lines, 
respectively. Both HGC-27 and DLD-1 cells were 
resistant to the bacterial cell wall fractions, whereas 
induced anti-proliferation effect by increasing 
cytoplasm fraction concentrations 23. These data 
suggest that cytoplasmic extraction may be 
responsible for L. GG action on proliferation in these 
two cell lines from gastric and colonic neoplasms23. 
In addition, another study showed the cytotoxicity 
effect of cell wall extracted from Lactobacillus casei 
and paracasei on K562 cell line. In mentioned study, 
the cell viability percentages with Lactobacillus 
casei’s cell wall doses in 2000 and 4000 µg/ml were 
less than 50% and in 500 and 1000 µg/ml were more 
than 50% in 24, 48 and 72h. The cell viability 
percentages with Lactobacillus paracasei’s cell wall 
doses in 2000 and 4000 µg/ml were less than 50% 
and in 500 µg/ml were more than 50% in 24, 48 and 
72h. The 1000 µg/ml was less than 50% in 24h and 
more than 50% in 48 and 72h. The 500 µg/ml was 
more than 50% in 24h and less than 50% in 48 and 
72h24. While our study showed that the cell viability 
percentages with Lactobacillus reuteri’s cell wall 
doses in 250 µg/ml is more than 50% and in 1000 
and 2000 µg/ml are less than 50% in 24, 48 and 72h. 
 
Conclusion 
Our study demonstrated that cell wall of L. reuteri 
inhibited cell proliferation of HCT-116 cell line. The 
inhibitory effect increasing with increased dose and 
time. 
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